Contents
In the Eagleville Hospital fraud case, the hospital agreed to pay $2.85 million to resolve allegations that it billed for hospital-level detoxification when patients qualified only for lower-level residential treatment or the claims lacked supporting documentation. The settlement covered claims from January 2011 through December 2018. For someone working in admissions, clinical care or billing, the case turns on a familiar decision: what level of treatment the patient needed, and how that decision became a claim.
The settlement concerned Eagleville Hospital’s substance use disorder treatment in Eagleville, Pennsylvania. The government announced the settlement in July 2019. A whistleblower brought the qui tam case behind the resolution.
The whistleblower alleged that Eagleville admitted certain groups of patients to higher-reimbursing hospital-level detoxification instead of residential treatment without satisfying the medical necessity requirements.
That allegation puts the admission decision at the center of the billing case. Hospital and residential treatment are different settings and payment categories. A patient’s need for substance use disorder treatment, the setting appropriate for that patient and the service billed all have to connect.
We see a straightforward wrong in the allegation: taxpayers funding a hospital-level bill when the patient’s needs called for residential care. The higher payment was supposed to follow the clinical need.
A separate Acadia Healthcare settlement announced in 2024 shows how the same question can extend through a stay. The government alleged unnecessary inpatient admissions and extended stays, along with missing active treatment and inadequate staffing. Those allegations put both entry into inpatient care and the decision to keep someone there under scrutiny.
For a detox billing case, that gives an insider a concrete point of comparison: the clinical reason for the level of care on each claim. We examine how the admission assessment, treatment record and billing decision fit together.
In a hospital detox billing case, we look for evidence connecting the patient’s assessed needs, the care delivered and the level billed to a particular payer. In Eagleville’s case, the government alleged hospital-level admissions for ineligible patients and claims without supporting documentation.
Those allegations focus attention on different parts of the hospital’s work:
The distinction matters beyond detox admissions. In the New Life Lodge case resolved in 2014, a former billing employee brought allegations against its operator, CRC Health Corporation. The government alleged TennCare claims for therapy that was not delivered or was delivered by unlicensed therapists, along with inadequate staffing and other deficiencies. A billing employee’s view of the claim can connect with a clinician’s view of what the patient received.
An authorization can also carry a false account forward. In a separate complaint against Universal Health Services concerning Medicaid children at Keystone Marion Youth Center, the government alleged that false treatment plans secured authorization for confinement. The billing followed:
UHS’s CBO managers and employees prepared and presented claims for room and board for each Medicaid child referencing the fraudulently obtained prior authorization approval codes, thereby incorporating into these claims the false records or statements used to obtain approval of prior authorization.
United States v. Universal Health Services, government amended complaint, paragraph 21(b)
An approval code doing a false plan’s work. That allegation is why we examine the clinical support behind an authorization alongside the claim that used it. For Eagleville, the question remains the hospital-level admission and the documentation supporting that level of detox treatment.
The Eagleville allegations covered Medicare, Medicaid and the Federal Employees Health Benefits Program. The whistleblower alleged that the admission practice generated false claims to all three.
The practical connection in health care billing is between departments as much as documents. An admissions worker may know how the level was selected. A clinician may know what the assessment supported. A billing worker may know how that decision appeared in the request for payment. Our work brings those views together around the same care and claim.
The Eagleville settlement resolved allegations in a whistleblower’s False Claims Act complaint. The U.S. Attorney’s Office for the Eastern District of Pennsylvania handled the case, assisted by investigators from the Department of Health and Human Services Office of Inspector General and the Office of Personnel Management Office of Inspector General.
The Justice Department credited the whistleblower with bringing the matter to its attention and announced that the whistleblower would receive a share of the recovery.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
Alongside the civil settlement, Eagleville entered a five-year corporate integrity agreement with the Department of Health and Human Services Office of Inspector General. It required the hospital to identify and address compliance risks through internal review, with training, auditing and monitoring aimed at the billing conduct in the case.
Speak to one of our whistleblower experts about detox admissions billed above the care the clinical record supports. We build the case with you and bring in healthcare fraud whistleblower lawyers who understand hospital admissions, medical necessity and payment records. We stay beside you through the process to build your strongest hospital billing whistleblower case.